These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31087421)

  • 1. Effects of growth hormone therapy on metabolic parameters, adipokine and endothelial dysfunction in prepuberal children.
    Cañete MD; Valle-Martos R; Martos R; Cañete R; Valle M; Jiménez-Reina L
    Acta Paediatr; 2019 Nov; 108(11):2027-2033. PubMed ID: 31087421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and prospective study of the effects of GH therapy on metabolic panel in children with GH deficiency.
    Ramistella V; Wasniewska M; Arasi S; Catena M; Velletri MR; Corica D; Santucci S; De Luca F
    Pediatr Med Chir; 2014 Dec; 36(5-6):104. PubMed ID: 25669895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment.
    Meazza C; Elsedfy HH; Pagani S; Bozzola E; El Kholy M; Bozzola M
    Horm Metab Res; 2014 Mar; 46(3):219-23. PubMed ID: 24297484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in body composition, adipokines, ghrelin, and FGF23 in growth hormone-deficient children during rhGH therapy.
    Belceanu AD; Bîlha ŞC; Leuştean L; Ungureanu MC; Preda C
    Endokrynol Pol; 2024; 75(3):291-299. PubMed ID: 38923900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of growth hormone replacement therapy on adipokines, but not upon ghrelin.
    Belceanu AD; Bîlha ȘC; Vulpoi C; Brănișteanu DD
    Minerva Endocrinol (Torino); 2023 Dec; 48(4):411-419. PubMed ID: 34546018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins.
    Lanes R; Soros A; Gunczler P; Paoli M; Carrillo E; Villaroel O; Palacios A
    J Pediatr; 2006 Sep; 149(3):324-9. PubMed ID: 16939741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of GH treatment on coagulation, fibrinolysis, inflammation biomarkers, and insulin resistance status in prepubertal children with GH deficiency.
    Cañete R; Valle M; Martos R; Sánchez-Carrión A; Cañete MD; van Donkelaar EL
    Eur J Endocrinol; 2012 Aug; 167(2):255-60. PubMed ID: 22645201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapy.
    De Marco S; Marcovecchio ML; Caniglia D; De Leonibus C; Chiarelli F; Mohn A
    Growth Horm IGF Res; 2014 Oct; 24(5):216-20. PubMed ID: 25172154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.
    Ciresi A; Pizzolanti G; Leotta M; Guarnotta V; Teresi G; Giordano C
    J Endocrinol Invest; 2016 Sep; 39(9):1023-30. PubMed ID: 27126309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study.
    Capalbo D; Esposito A; Improda N; Wasniewska MG; Di Mase R; De Luca F; Bruzzese D; Salerno M
    Endocrine; 2018 Mar; 59(3):643-650. PubMed ID: 28875423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.
    Metwalley KA; Farghaly HS; Abd El-Hafeez HA
    Indian J Endocrinol Metab; 2013 Sep; 17(5):876-82. PubMed ID: 24083170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.
    López-Siguero JP; López-Canti LF; Espino R; Caro E; Fernández-García JM; Gutiérrez-Macías A; Rial JM; Lechuga JL; Macías F; Martínez-Aedo MJ; Rico S; Rodríguez I; Guillén J; Arroyo FJ; Bernal S; Espigares R; Núñez M; Escribano A; Barrionuevo JL; Gentil J; Barrios V; Fernández-Nistal A; Martos-Moreno GA; Martínez V; Argente J
    J Endocrinol Invest; 2011 Apr; 34(4):300-6. PubMed ID: 20634639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
    Capalbo D; Mattace Raso G; Esposito A; Di Mase R; Barbieri F; Meli R; Bruzzese D; Salerno M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):856-62. PubMed ID: 24372071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
    Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
    Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
    Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
    Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations between the growth hormone/insulin-like growth factor-1 axis, adiponectin, resistin and metabolic profile in children with growth hormone deficiency before and during growth hormone treatment.
    Witkowska-Sędek E; Rumińska M; Stelmaszczyk-Emmel A; Majcher A; Pyrżak B
    Acta Biochim Pol; 2018; 65(2):333-340. PubMed ID: 29913483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of glucose and lipid metabolism and bone mineralization in patients with growth hormone deficiency with and without long-term growth hormone replacement.
    Roemmler J; Kuenkler M; Schneider HJ; Dieterle C; Schopohl J
    Metabolism; 2010 Mar; 59(3):350-8. PubMed ID: 19800640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.